Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-27

Clinical Trial Update: Second Uterine Evacuation for Low-risk Gestational Trophoblastic Neoplasia [Phase 3]

View source ↗

Summary

Phase 3 trial update on second uterine evacuation for low-risk gestational trophoblastic neoplasia (GTT) is in progress; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Gestational Trophoblastic Neoplasia, Molar Pregnancy | Phase 3 | Status: UNKNOWN